Diligence memo · auto-generated · as of July 2, 2026
Spinogenix, Inc.
Spinogenix, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Spinogenix, Inc. operates in Other Health Care, based in LOS ANGELES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Spinogenix, Inc. has raised $25M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2025-11-21.
Most recent recorded round closed around 2025-11-21.
Valuation (modeled)modeled
Provath models Spinogenix, Inc. at approximately $31M (range $14M–$49M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.90× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 7 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 3.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 86% of Other Health Care peers (5377 compared).
Modeled value ranks above 59% of those peers.
Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Medmo, Inc., Vertical Orthopaedics, Inc..
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.